KMTS
Kestra Medical Technologies, Ltd. NASDAQ$20.55
Mkt Cap $1.2B
52w Low $13.25
43.6% of range
52w High $30.00
50d MA $21.38
200d MA $22.60
P/E (TTM)
-4.2x
EV/EBITDA
-10.2x
P/B
5.3x
Debt/Equity
0.2x
ROE
-80.1%
P/FCF
-11.8x
RSI (14)
—
ATR (14)
—
Beta
1.09
50d MA
$21.38
200d MA
$22.60
Avg Volume
358.3K
About
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeu…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | AMC | -0.60 | -0.61 | -1.7% | 21.14 | +0.0% | -7.4% | -7.5% | -9.7% | -7.3% | -2.1% | — |
| Dec 11, 2025 | AMC | -0.59 | -0.62 | -4.4% | 24.91 | +6.2% | +5.1% | +6.3% | +8.4% | +7.7% | +9.0% | — |
| Sep 11, 2025 | AMC | -0.66 | -0.46 | +30.3% | 18.40 | +8.7% | +18.6% | +23.3% | +26.1% | +29.0% | +37.0% | — |
| Jul 17, 2025 | AMC | — | -1.05 | — | 16.46 | +2.1% | -3.4% | +1.0% | +3.5% | +1.6% | +3.1% | — |
| Apr 30, 2024 | AMC | — | -0.45 | — | — | — | — | — | — | — | — | — |
| Jan 31, 2024 | AMC | — | -0.44 | — | — | — | — | — | — | — | — | — |
| Jul 31, 2021 | AMC | — | -0.27 | — | — | — | — | — | — | — | — | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 9 | Goldman Sachs | Maintains | Neutral → Neutral | — | $19.62 | $19.31 | -1.6% | -1.9% | -8.9% | -4.4% | +0.6% | +2.9% |
| Apr 7 | BTIG | Maintains | Buy → Buy | — | $19.32 | $19.18 | -0.7% | +0.9% | +1.6% | -0.4% | -7.5% | -2.9% |
| Mar 25 | BTIG | Maintains | Buy → Buy | — | $20.70 | $20.75 | +0.2% | -0.6% | -4.9% | -6.0% | -11.4% | -3.7% |
| Mar 18 | BTIG | Maintains | Buy → Buy | — | $21.14 | $21.14 | +0.0% | -7.4% | -7.5% | -9.7% | -7.3% | -2.1% |
| Dec 15 | Goldman Sachs | Maintains | Neutral → Neutral | — | $26.17 | $26.15 | -0.1% | +1.2% | +3.2% | +2.5% | +3.7% | +4.4% |
| Dec 12 | Piper Sandler | Maintains | Overweight → Overweight | — | $24.91 | $26.45 | +6.2% | +5.1% | +6.3% | +8.4% | +7.7% | +9.0% |
| Dec 12 | Wells Fargo | Maintains | Overweight → Overweight | — | $24.91 | $26.45 | +6.2% | +5.1% | +6.3% | +8.4% | +7.7% | +9.0% |
| Jul 17 | Wells Fargo | Maintains | Overweight → Overweight | — | $15.35 | $15.30 | -0.3% | +7.2% | +3.6% | +8.3% | +10.9% | +8.9% |
| Apr 16 | Goldman Sachs | Maintains | Neutral → Neutral | — | $24.13 | $24.08 | -0.2% | +1.9% | +1.5% | -2.4% | -0.5% | +0.9% |
Recent Filings
Data updated apr 25, 2026 5:42pm
· Source: massive.com